Prognostic Value of Stem Cell Related Markers

NCT01265225 | Withdrawn DMC

• 1 other identifier: 10.CTIL
• Study Type: observational
• Target: N/A
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of the investigators study is to identify a prognostic marker that will evaluate the probability of recurrence in patients with stage 0-II breast cancer following surgery to remove the tumor.

Conditions

Breast Cancer

Keywords

breast cancer stages 0-II

Eligibility Criteria

• Age: 18 Years+
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

100 tumor specimens from women with grade 0-11 ductal breast cancer

You may qualify if:

• Ductal Carcinoma in Situ
• DCIS + Microinvasion stages 1 or 11 without positive lymph nodes

You may not qualify if:

• tumor specimen with higher than grade II
• BRACA 1 or BRACA 2 mutation
• Neoadjuvant chemotherapy

Sponsors & Collaborators

• The Baruch Padeh Medical Center, Poriya: lead

Study Sites (1)

Baruch PMC

Poria – Neve Oved, Lower Galilee, 15208, Israel

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Sponsor Type: OTHER GOV

Study Record Dates

• First Submitted: December 21, 2010
• First Posted: December 23, 2010
• Study Start: February 1, 2011
• Primary Completion: February 1, 2013
• Study Completion: April 1, 2013
• Last Updated: December 24, 2013

Record last verified: 2013-12

Locations

IL (1)